{"DataElement":{"publicId":"2467357","version":"1","preferredName":"Prior Registration Screening Patient Clinical Trial Ineligibility Reason","preferredDefinition":"the reason a patient or participant was deemed ineligible for participation on a clinical trial by preregistration screening or assessment.","longName":"PR_RE_SC_PT_CT_IN_RS","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2467354","version":"1","preferredName":"Prior Registration Screening Patient Clinical Trial Ineligibility","preferredDefinition":"information related to a patient or participant being disqualified by law, rule, or provision from participating in a clinical trial by a systematic examination or assessment performed before registration or enrollment.","longName":"PR_REG_SCR_PT_CT_INE","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2467351","version":"1","preferredName":"Prior Registration Screening Patient","preferredDefinition":"Earlier in time or order.:Registration; the act of enrolling.:A systematic examination or assessment.:A person who requires medical care.","longName":"C25629:C25646:C48261:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Registration","conceptCode":"C25646","definition":"The act of listing or recording officially; officially qualified or enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Screening","conceptCode":"C48261","definition":"A systematic examination or assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"104B9950-91F9-1509-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"ONEDATA","dateModified":"2006-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2467352","version":"1","preferredName":"Clinical Trial Ineligibility","preferredDefinition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical study.:The state or quality of being disqualified by law, rule, or provision.","longName":"C15207:C40412","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial","conceptCode":"C15207","definition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ineligibility","conceptCode":"C40412","definition":"The state or quality of being disqualified by law, rule, or provision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"104B9950-920A-1509-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"ONEDATA","dateModified":"2006-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"104B9950-921B-1509-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2467355","version":"1","preferredName":"Screening Clinical Trial Ineligibility Reason","preferredDefinition":"the reason for ineligibility or disqualification for participation on a clinical trial resulting from screening or assessment.","longName":"SCR_CT_INELIG_RSN","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Investigator decision","valueDescription":"Investigator decision","ValueMeaning":{"publicId":"2578434","version":"1","preferredName":"Investigator decision","longName":"2578434","preferredDefinition":"The decision of the investigator","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF6F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"CAMPBELB","dateModified":"2006-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104BD384-8296-176B-E044-0003BA3F9857","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"ONEDATA","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Did not meet eligibility criteria","valueDescription":"Did not meet eligibility criteria","ValueMeaning":{"publicId":"2578433","version":"1","preferredName":"Did not meet eligibility criteria","longName":"2578433","preferredDefinition":"Did not meet eligibility criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF6E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"CAMPBELB","dateModified":"2006-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104BD384-8284-176B-E044-0003BA3F9857","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"ONEDATA","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Patient decision","valueDescription":"Patient decision","ValueMeaning":{"publicId":"2578435","version":"1","preferredName":"Patient decision","longName":"2578435","preferredDefinition":"The decision of the patient","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF70-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"CAMPBELB","dateModified":"2006-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104BD384-82A8-176B-E044-0003BA3F9857","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"ONEDATA","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104BD384-82B4-176B-E044-0003BA3F9857","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"ONEDATA","dateModified":"2006-03-31","deletedIndicator":"No"},{"value":"Not evaluable for FISH","valueDescription":"Not evaluable for FISH","ValueMeaning":{"publicId":"2732306","version":"1","preferredName":"Not evaluable for FISH","longName":"2732306","preferredDefinition":"Not evaluable for FISH","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"473D71E3-39DC-7297-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-02-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"473D79B8-1CB4-7511-E044-0003BA3F9857","beginDate":"2008-02-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-02-28","modifiedBy":"SHIDED","dateModified":"2008-02-28","deletedIndicator":"No"},{"value":"Not evaluable for KRAS","valueDescription":"Not evaluable for KRAS","ValueMeaning":{"publicId":"2787609","version":"1","preferredName":"Not evaluable for KRAS","longName":"2787609","preferredDefinition":"Not evaluable for KRAS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57BB446A-9AB6-3DDE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-25","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"57BB451B-8DF1-3F63-E044-0003BA3F9857","beginDate":"2008-09-25","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-25","modifiedBy":"ONEDATA","dateModified":"2008-09-25","deletedIndicator":"No"},{"value":"Not evaluable (per email notification)","valueDescription":"Not evaluable (per email notification)","ValueMeaning":{"publicId":"2859457","version":"1","preferredName":"Not evaluable (per email notification)","longName":"2859457","preferredDefinition":"Not evaluable (per email notification)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"667F71E6-776C-71D3-E040-BB89AD433240","latestVersionIndicator":"Yes","beginDate":"2009-04-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"667F71E6-7785-71D3-E040-BB89AD433240","beginDate":"2009-04-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-04-01","modifiedBy":"ONEDATA","dateModified":"2009-04-01","deletedIndicator":"No"},{"value":"Surgical failure per imaging","valueDescription":"Surgical failure per imaging (<90% of disease resected)","ValueMeaning":{"publicId":"3613418","version":"1","preferredName":"Surgical failure per imaging (<90% of disease resected)","longName":"3613418","preferredDefinition":"Surgical failure per imaging (<90% of disease resected)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBCE4E2C-1C5A-5B69-E040-BB89AD436425","latestVersionIndicator":"Yes","beginDate":"2012-10-11","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CBCE4E2C-1C73-5B69-E040-BB89AD436425","beginDate":"2012-10-11","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-11","modifiedBy":"ONEDATA","dateModified":"2012-10-11","deletedIndicator":"No"},{"value":"Surgical failure per surgeon","valueDescription":"Surgical failure per surgeon (<90% of disease resected)","ValueMeaning":{"publicId":"3613419","version":"1","preferredName":"Surgical failure per surgeon (<90% of disease resected)","longName":"3613419","preferredDefinition":"Surgical failure per surgeon (<90% of disease resected)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBCE4E2C-1C7D-5B69-E040-BB89AD436425","latestVersionIndicator":"Yes","beginDate":"2012-10-11","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CBCE4E2C-1C96-5B69-E040-BB89AD436425","beginDate":"2012-10-11","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-11","modifiedBy":"ONEDATA","dateModified":"2012-10-11","deletedIndicator":"No"},{"value":"Vaccine production failure","valueDescription":"Vaccine production failure","ValueMeaning":{"publicId":"3613420","version":"1","preferredName":"Vaccine production failure","longName":"3613420","preferredDefinition":"Vaccine production failure","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBCE4E2C-1CA0-5B69-E040-BB89AD436425","latestVersionIndicator":"Yes","beginDate":"2012-10-11","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CBCE4E2C-1CB9-5B69-E040-BB89AD436425","beginDate":"2012-10-11","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-11","modifiedBy":"ONEDATA","dateModified":"2012-10-11","deletedIndicator":"No"},{"value":"Inadequate amount of tumor resected for vaccine production","valueDescription":"Inadequate amount of tumor resected for vaccine production","ValueMeaning":{"publicId":"3613421","version":"1","preferredName":"Inadequate amount of tumor resected for vaccine production","longName":"3613421","preferredDefinition":"Inadequate amount of tumor resected for vaccine production","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBCE4E2C-1CC3-5B69-E040-BB89AD436425","latestVersionIndicator":"Yes","beginDate":"2012-10-11","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CBCE4E2C-1CDC-5B69-E040-BB89AD436425","beginDate":"2012-10-11","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-11","modifiedBy":"ONEDATA","dateModified":"2012-10-11","deletedIndicator":"No"},{"value":"RPFNA failure","valueDescription":"RPFNA failure","ValueMeaning":{"publicId":"3669420","version":"1","preferredName":"RPFNA failure","longName":"3669420","preferredDefinition":"RPFNA failure","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4851F80-522D-806D-E040-BB89AD434055","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4851F80-5246-806D-E040-BB89AD434055","beginDate":"2013-01-30","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Evidence of metastatic disease","valueDescription":"Evidence of metastatic disease","ValueMeaning":{"publicId":"3669421","version":"1","preferredName":"Evidence of metastatic disease","longName":"3669421","preferredDefinition":"Evidence of metastatic disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4851F80-5250-806D-E040-BB89AD434055","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4851F80-5269-806D-E040-BB89AD434055","beginDate":"2013-01-30","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Prior malignancy","valueDescription":"Prior malignancy","ValueMeaning":{"publicId":"3669422","version":"1","preferredName":"Prior malignancy","longName":"3669422","preferredDefinition":"Prior malignancy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4851F80-5273-806D-E040-BB89AD434055","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4851F80-528C-806D-E040-BB89AD434055","beginDate":"2013-01-30","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-01-30","modifiedBy":"ONEDATA","dateModified":"2013-01-30","deletedIndicator":"No"},{"value":"Deemed ineligible per central biomarker testing","valueDescription":"Ineligibility Per Center Biomarker Testing","ValueMeaning":{"publicId":"6618764","version":"1","preferredName":"Ineligibility Per Center Biomarker Testing","longName":"6618764","preferredDefinition":"The state or quality of being disqualified by law, rule, or provision.: For each, generally denoting a ratio.: A point or area that is approximately central within some larger region or structure.: A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.: A procedure for critical evaluation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ineligibility","conceptCode":"C40412","definition":"The state or quality of being disqualified by law, rule, or provision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Per","conceptCode":"C65039","definition":"For each, generally denoting a ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Center","conceptCode":"C25445","definition":"A point or area that is approximately central within some larger region or structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Testing","conceptCode":"C15336","definition":"A procedure for critical evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80470DBF-C6A4-4B53-E053-F662850AF963","latestVersionIndicator":"Yes","beginDate":"2019-01-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-25","modifiedBy":"ONEDATA","dateModified":"2019-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"80470DBF-C6BD-4B53-E053-F662850AF963","beginDate":"2019-01-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-25","modifiedBy":"ONEDATA","dateModified":"2019-01-25","deletedIndicator":"No"},{"value":"Registration to cohort unavailable","valueDescription":"Registration To Cohort Not Available","ValueMeaning":{"publicId":"6618765","version":"1","preferredName":"Registration To Cohort Not Available","longName":"6618765","preferredDefinition":"The act of listing or recording officially; officially qualified or enrolled.: Used as a function word to indicate direction, purpose, or movement.: A group of individuals, identified by a common characteristic.: The desired information is not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Registration","conceptCode":"C25646","definition":"The act of listing or recording officially; officially qualified or enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Available","conceptCode":"C126101","definition":"The desired information is not available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80470DBF-C6CC-4B53-E053-F662850AF963","latestVersionIndicator":"Yes","beginDate":"2019-01-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-25","modifiedBy":"ONEDATA","dateModified":"2019-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"80470DBF-C6E5-4B53-E053-F662850AF963","beginDate":"2019-01-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-25","modifiedBy":"ONEDATA","dateModified":"2019-01-25","deletedIndicator":"No"},{"value":"Did not meet other eligibility criteria","valueDescription":"Negation Fulfill Other Clinical Trial Eligibility Criteria","ValueMeaning":{"publicId":"6840993","version":"1","preferredName":"Negation Fulfill Other Clinical Trial Eligibility Criteria","longName":"6840993","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Satisfy the requirements or expectations of.: Different than the one(s) previously specified or mentioned.: Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Fulfill","conceptCode":"C87531","definition":"Satisfy the requirements or expectations of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9C8F7-6B6C-243E-E053-F662850AC5C2","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9C8F7-6B85-243E-E053-F662850AC5C2","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Insufficient tissue to centrally confirm diagnosis of DLBCL and non-GCB subtype","valueDescription":"Inadequate Normal Tissue To Center Confirmation Diagnosis Diffuse Large B-Cell Lymphoma And Negation Germinal Center B-Cell Gene Expression Signature Subtype","ValueMeaning":{"publicId":"6840994","version":"1","preferredName":"Inadequate Normal Tissue To Center Confirmation Diagnosis Diffuse Large B-Cell Lymphoma And Negation Germinal Center B-Cell Gene Expression Signature Subtype","longName":"6840994","preferredDefinition":"Not meeting a quantitative or qualitative measure necessary for a requirement.: An anatomical structure, which consists of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships. Examples: epithelium, muscle tissue, connective tissue, neural tissue, lymphoid tissue.: Used as a function word to indicate direction, purpose, or movement.: A point or area that is approximately central within some larger region or structure.: Having been established or verified.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.: A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An operation in which a term denies or inverts the meaning of another term or construction.: A gene expression profile found in a subset of diffuse large B-cell lymphomas. This expression profile is associated with better overall survival.: A group forming a type within a larger type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"10"},{"longName":"Normal Tissue","conceptCode":"C33177","definition":"An anatomical structure, which consists of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships. Examples: epithelium, muscle tissue, connective tissue, neural tissue, lymphoid tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"9"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"8"},{"longName":"Center","conceptCode":"C25445","definition":"A point or area that is approximately central within some larger region or structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Germinal Center B-Cell Gene Expression Signature","conceptCode":"C120019","definition":"A gene expression profile found in a subset of diffuse large B-cell lymphomas. This expression profile is associated with better overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9C8F7-6B9B-243E-E053-F662850AC5C2","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9C8F7-6BB4-243E-E053-F662850AC5C2","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Sufficient tissue, but failure to confirm non-GCB subtype","valueDescription":"Sufficient Normal Tissue Failure Confirmation Negation Germinal Center B-Cell Gene Expression Signature Subtype","ValueMeaning":{"publicId":"6840995","version":"1","preferredName":"Sufficient Normal Tissue Failure Confirmation Negation Germinal Center B-Cell Gene Expression Signature Subtype","longName":"6840995","preferredDefinition":"Meeting a quantitative or qualitative measure necessary for a requirement; enough to meet the needs of a situation.: An anatomical structure, which consists of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships. Examples: epithelium, muscle tissue, connective tissue, neural tissue, lymphoid tissue.: A lack of occurrence or performance.: Having been established or verified.: An operation in which a term denies or inverts the meaning of another term or construction.: A gene expression profile found in a subset of diffuse large B-cell lymphomas. This expression profile is associated with better overall survival.: A group forming a type within a larger type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sufficient","conceptCode":"C63351","definition":"Meeting a quantitative or qualitative measure necessary for a requirement; enough to meet the needs of a situation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Normal Tissue","conceptCode":"C33177","definition":"An anatomical structure, which consists of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships. Examples: epithelium, muscle tissue, connective tissue, neural tissue, lymphoid tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Germinal Center B-Cell Gene Expression Signature","conceptCode":"C120019","definition":"A gene expression profile found in a subset of diffuse large B-cell lymphomas. This expression profile is associated with better overall survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9C8F7-6BC6-243E-E053-F662850AC5C2","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9C8F7-6BDF-243E-E053-F662850AC5C2","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"ABC subtype not assessed","valueDescription":"Activated B-Cell Positive Subtype Not Assessed","ValueMeaning":{"publicId":"6840996","version":"1","preferredName":"Activated B-Cell Positive Subtype Not Assessed","longName":"6840996","preferredDefinition":"An indication that actively proliferating and differentiating B-lymphocytes have been detected in a sample.: A group forming a type within a larger type.: Indicates that an assessment was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activated B-Cell Positive","conceptCode":"C142124","definition":"An indication that actively proliferating and differentiating B-lymphocytes have been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Assessed","conceptCode":"C139527","definition":"Indicates that an assessment was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9C8F7-6BED-243E-E053-F662850AC5C2","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9C8F7-6C06-243E-E053-F662850AC5C2","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Absence of ABC subtype","valueDescription":"Negation Activated B-Cell Positive Subtype","ValueMeaning":{"publicId":"6840997","version":"1","preferredName":"Negation Activated B-Cell Positive Subtype","longName":"6840997","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: An indication that actively proliferating and differentiating B-lymphocytes have been detected in a sample.: A group forming a type within a larger type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Activated B-Cell Positive","conceptCode":"C142124","definition":"An indication that actively proliferating and differentiating B-lymphocytes have been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9C8F7-6C14-243E-E053-F662850AC5C2","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9C8F7-6C2D-243E-E053-F662850AC5C2","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Disease criteria not confirmed pathologically","valueDescription":"Disease or Disorder Criterion Negation Confirmation Pathology","ValueMeaning":{"publicId":"6840998","version":"1","preferredName":"Disease or Disorder Criterion Negation Confirmation Pathology","longName":"6840998","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.: That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.: An operation in which a term denies or inverts the meaning of another term or construction.: Having been established or verified.: The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pathology","conceptCode":"C18189","definition":"The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9C8F7-6C3D-243E-E053-F662850AC5C2","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9C8F7-6C56-243E-E053-F662850AC5C2","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"Sufficient tissue, but failure to confirm DLBCL diagnosis","valueDescription":"Sufficient Normal Tissue Failure To Confirmation Diffuse Large B-Cell Lymphoma Diagnosis","ValueMeaning":{"publicId":"6840999","version":"1","preferredName":"Sufficient Normal Tissue Failure To Confirmation Diffuse Large B-Cell Lymphoma Diagnosis","longName":"6840999","preferredDefinition":"Meeting a quantitative or qualitative measure necessary for a requirement; enough to meet the needs of a situation.: An anatomical structure, which consists of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships. Examples: epithelium, muscle tissue, connective tissue, neural tissue, lymphoid tissue.: A lack of occurrence or performance.: Used as a function word to indicate direction, purpose, or movement.: Having been established or verified.: A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sufficient","conceptCode":"C63351","definition":"Meeting a quantitative or qualitative measure necessary for a requirement; enough to meet the needs of a situation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Normal Tissue","conceptCode":"C33177","definition":"An anatomical structure, which consists of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships. Examples: epithelium, muscle tissue, connective tissue, neural tissue, lymphoid tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EE9C8F7-6C68-243E-E053-F662850AC5C2","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8EE9C8F7-6C81-243E-E053-F662850AC5C2","beginDate":"2019-07-30","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-30","modifiedBy":"ONEDATA","dateModified":"2019-07-30","deletedIndicator":"No"},{"value":"No eligible mutation","valueDescription":"No eligible mutation","ValueMeaning":{"publicId":"7092218","version":"1","preferredName":"No eligible mutation","longName":"7092218","preferredDefinition":"No eligible mutation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"998552D5-1648-31E0-E053-F662850A7235","latestVersionIndicator":"Yes","beginDate":"2019-12-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-12-12","modifiedBy":"ONEDATA","dateModified":"2019-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"998552D5-1661-31E0-E053-F662850A7235","beginDate":"2019-12-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-12-12","modifiedBy":"ONEDATA","dateModified":"2019-12-12","deletedIndicator":"No"},{"value":"Biomarker cohort closed","valueDescription":"Biomarker cohort closed","ValueMeaning":{"publicId":"7092219","version":"1","preferredName":"Biomarker cohort closed","longName":"7092219","preferredDefinition":"Biomarker cohort closed","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"998552D5-166B-31E0-E053-F662850A7235","latestVersionIndicator":"Yes","beginDate":"2019-12-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-12-12","modifiedBy":"ONEDATA","dateModified":"2019-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"998552D5-1684-31E0-E053-F662850A7235","beginDate":"2019-12-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-12-12","modifiedBy":"ONEDATA","dateModified":"2019-12-12","deletedIndicator":"No"},{"value":"DCIS or invasive disease in contralateral breast","valueDescription":"Contralateral Invasive Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"7187220","version":"1","preferredName":"Contralateral Invasive Ductal Breast Carcinoma In Situ","longName":"7187220","preferredDefinition":"On or relating to the opposite side of the body.: Marked by a tendency to spread, especially into healthy surrounding tissue.: A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contralateral","conceptCode":"C25307","definition":"On or relating to the opposite side of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FF4B71C-37D1-4942-E053-F662850AAA0F","latestVersionIndicator":"Yes","beginDate":"2020-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-03-03","modifiedBy":"ONEDATA","dateModified":"2020-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9FF4B71C-37EA-4942-E053-F662850AAA0F","beginDate":"2020-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-03-03","modifiedBy":"ONEDATA","dateModified":"2020-03-03","deletedIndicator":"No"},{"value":"More than 8 lymph nodes excised by the surgeon","valueDescription":"More than 8 lymph nodes excised by the surgeon","ValueMeaning":{"publicId":"7187221","version":"1","preferredName":"More than 8 lymph nodes excised by the surgeon","longName":"7187221","preferredDefinition":"More than 8 lymph nodes excised by the surgeon","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FF4B71C-37F4-4942-E053-F662850AAA0F","latestVersionIndicator":"Yes","beginDate":"2020-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-03-03","modifiedBy":"ONEDATA","dateModified":"2020-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9FF4B71C-380D-4942-E053-F662850AAA0F","beginDate":"2020-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-03-03","modifiedBy":"ONEDATA","dateModified":"2020-03-03","deletedIndicator":"No"},{"value":"All SLNs found to be negative for disease","valueDescription":"Negative Finding Disease or Disorder Sentinel Lymph Node","ValueMeaning":{"publicId":"7187222","version":"1","preferredName":"Negative Finding Disease or Disorder Sentinel Lymph Node","longName":"7187222","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.: The first lymph node to which cancer is likely to spread from the primary tumor. Cancer cells may appear first in the sentinel node before spreading to other lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sentinel Lymph Node","conceptCode":"C12947","definition":"The first lymph node that is affected by cancer spread from the primary site.  Sentinel lymph node biopsy is part of the staging work-up to determine early metastasis to regional lymph nodes in patients with breast carcinoma or melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FF4B71C-381B-4942-E053-F662850AAA0F","latestVersionIndicator":"Yes","beginDate":"2020-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-03-03","modifiedBy":"ONEDATA","dateModified":"2020-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9FF4B71C-3834-4942-E053-F662850AAA0F","beginDate":"2020-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-03-03","modifiedBy":"ONEDATA","dateModified":"2020-03-03","deletedIndicator":"No"},{"value":"Inability to identify SLN","valueDescription":"No Identification Sentinel Lymph Node","ValueMeaning":{"publicId":"7187223","version":"1","preferredName":"No Identification Sentinel Lymph Node","longName":"7187223","preferredDefinition":"The non-affirmative response to a question.: The procedure of having an identity established.: The first lymph node to which cancer is likely to spread from the primary tumor. Cancer cells may appear first in the sentinel node before spreading to other lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sentinel Lymph Node","conceptCode":"C12947","definition":"The first lymph node that is affected by cancer spread from the primary site.  Sentinel lymph node biopsy is part of the staging work-up to determine early metastasis to regional lymph nodes in patients with breast carcinoma or melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FF4B71C-3842-4942-E053-F662850AAA0F","latestVersionIndicator":"Yes","beginDate":"2020-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-03-03","modifiedBy":"ONEDATA","dateModified":"2020-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9FF4B71C-385B-4942-E053-F662850AAA0F","beginDate":"2020-03-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-03-03","modifiedBy":"ONEDATA","dateModified":"2020-03-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"104BAAE1-74F7-1656-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"CAMPBELB","dateModified":"2020-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PR_RE_SC_PT_CT_IN_RS","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Primary reason screening fail","type":"Preferred Question Text","description":"Primary reason screening failed","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Which screening criteria not met?","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"which screening criteria not met?","url":null,"context":"Alliance"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"104BBD93-77F3-1767-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"MORENOC","dateModified":"2019-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}